2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, S | 1 |
| Chen, T | 1 |
| Yu, X | 1 |
| Luo, M | 1 |
| Chen, X | 1 |
| Lin, C | 1 |
| Lai, Y | 1 |
| Huang, H | 1 |
| Kosaka, T | 1 |
| Miyajima, A | 1 |
| Shirotake, S | 1 |
| Kikuchi, E | 1 |
| Oya, M | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell | 2017 |
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Proteins; Cell Line, Tumor; Chromones; Enzym | 2011 |